Symptomatic Infection

The updated COVID-19 vaccines were approximately 54% effective against symptomatic SARS-CoV-2 infection and offered protection against JN.1 and XBB viral lineages, according to early estimates published Thursday by the CDC.

Earlier this year, a national report card noted the primary care field is headed for a crisis due to underinvestment, poor accessibility and other factors.